Clinically, XRCC5 and XRCC6 single nucleotide polymorphisms as well as epigenetic silencing of these genes can lead to the development of multiple cancers, such as CRC, breast and lung cancer [47]. This evidence concerns the gene XRCC6 and lung cancer.